Showing results (1871-1880 of 3,794) with videos related to
Sort By:
Pageof 380
Oncoimmunology|March 5, 2016
The role of NF-kB in modulating antitumor immunityAnn Richmond, Jinming YangOncoimmunology|March 5, 2016
(Compl)Ex-Th17-Treg cell inter-relationshipNataša Obermajer, Marc H DahlkeOncoimmunology|March 5, 2016
Cryoablation and Meriva have strong therapeutic effect on triple-negative breast cancerDinesh Chandra, Arthee Jahangir, Francois Cornelis, et al.Oncoimmunology|March 5, 2016
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosisEmilia Andersson, Isabel Poschke, Lisa Villabona, et al.Oncoimmunology|March 5, 2016
Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma modelsMarine M Leblond, Aurélie N Gérault, Aurélien Corroyer-Dulmont, et al.Oncoimmunology|March 5, 2016
Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cellsGayathri Natarajan, Cesar Terrazas, Steve Oghumu, et al.Oncoimmunology|March 5, 2016
All that glitters is not gold: the need to consider desirable and undesirable immune aspects of oncolytic virus therapyDerek R Clements, Youra Kim, Shashi A Gujar, et al.Oncoimmunology|March 5, 2016
CD11b+Ly6G+ cells inhibit tumor growth by suppressing IL-17 production at early stages of tumorigenesisYuhong Liu, Claire E O'Leary, Liang-Chuan S Wang, et al.Oncoimmunology|March 5, 2016
Long-lasting multifunctional CD8+ T cell responses in end-stage melanoma patients can be induced by dendritic cell vaccinationFlorian Wimmers, Erik H J G Aarntzen, Tjitske Duiveman-deBoer, et al.Oncoimmunology|March 5, 2016
Targeting TNF alpha as a novel strategy to enhance CD8+ T cell-dependent immune response in melanoma?Florie Bertrand, Julia Rochotte, Céline Colacios, et al.Pageof 380